Your Partner For Impact

From neurological and respiratory diseases to endocrinology and medical devices, we bring deep expertise across diverse therapeutic areas.

With therapeutic‑specific teams and extensive global site networks, we deliver end‑to‑end services designed to change lives⁠—⁠advancing innovations that help evolve clinical practice worldwide.

See how we can help

Our Areas of Excellence

Renal

Lead advancements in renal care with access to a unique, award‑winning global site network. Together, we set the standard for renal trials, delivering innovative solutions that improve patient outcomes.

Discover renal expertise

Cardiometabolic

Shape the future of cardiovascular and metabolic care with deep expertise and innovative trial designs. Backed by a track record of real‑world impact, we advance meaningful solutions for patients worldwide.

Get cardiometabolic results

Oncology

Streamline complex oncology research from early phase to rescue trials. Global site networks, scientific leadership, and custom strategies help you reach patients faster.

Advance oncology research

Global Support for Every Trial

Whether you are looking for a neuroscience CRO, medical device CRO, or something else, choose the people dedicated to your success. With local teams worldwide, we streamline, simplify, and deliver consistently across diverse therapeutic areas.

World map of George Clinical locations

Featured Resources

Driving Pancreatic Cancer Progress

Discover how we saved a trial from closure through regulatory expertise and exceptional operational efficiency.

Exceeding Recruitment Targets in IgAN

See how our Scientific Leadership model drove optimum recruitment for this milestone rare disease trial.

Patient‑First, From Design to Delivery

Explore how our global site alliances and flexible, human approach supported Phase I oncology trial success in Australia.

End‑to‑End Services Support FDA Approval

Read how we provided a full service for a Phase II multicenter IgAN study that resulted in full FDA approval.